BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3879053)

  • 1. [Does rehydration improve hemoccult screening for intestinal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1985 Dec; 23(12):676-80. PubMed ID: 3879053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH; Gnauck R
    Z Gastroenterol; 1987 Sep; 25(9):607-11. PubMed ID: 3673146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal dietary conditions for hemoccult testing.
    Macrae FA; St John DJ; Caligiore P; Taylor LS; Legge JW
    Gastroenterology; 1982 May; 82(5 Pt 1):899-903. PubMed ID: 7060911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of the study of occult fecal blood with Hemoccult II in 211 symptomatic patients controlled by total colonoscopy].
    Morini S; Manurita L; Stroppa I; Bassi O
    Minerva Med; 1984 Apr; 75(17):963-6. PubMed ID: 6728249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Informative value of Hemoccult test according to the number of positive slides in mass screening of colorectal cancer].
    Tazi MA; Faivre J; Lejeune C; Dassonville F; Benhamiche AM
    Bull Cancer; 1998 Dec; 85(12):1055-9. PubMed ID: 9917557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemoccult test--screening].
    Z Gastroenterol; 1987 Mar; 25(3):185-94. PubMed ID: 3590898
    [No Abstract]   [Full Text] [Related]  

  • 10. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Territorial mass screening for colorectal tumors].
    Dall'Acqua S; Tessera G; De Bernardi A; Paganelli M; Schettino F; Fiaccadori C; Ghidorsi F; Reggiori G; Bono P; Reggiori A
    Minerva Chir; 1988 Mar; 43(6):519-23. PubMed ID: 3399109
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in SaĆ“ne-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of the Hemoccult II slide test in detecting colonic neoplasms.
    Poleski MH; Gordon PH
    Can J Surg; 1986 Mar; 29(2):99-101. PubMed ID: 3955472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
    Gnauck R
    Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA; Judd L; Sanford NS
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.